Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 10/20 | 1.00 |
| ▸ | SPHK2 | Q9NRA0 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | TRPM2 | O94759 | 2/20 | 0.40 |
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.40 |
| ▸ | CYSLTR1 | Q9Y271 | 2/20 | 0.40 |
| ▸ | ASAH2 | Q9NR71 | 1/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.40 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.40 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 2/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.40 |
| ▸ | TACR2 | P21452 | 2/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14633002 | 1.00 | SPHK1 (1.00) | SPHK1SPHK2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL20592376 | 1.00 | SPHK1 (1.00) | SPHK1SPHK2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL18194573 | 1.00 | SPHK1 (1.00) | SPHK1SPHK2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL20596127 | 1.00 | SPHK1 (1.00) | SPHK1SPHK2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL23519479 | 0.99 | SPHK1 (0.97) | SPHK1SPHK2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL13896120 | 0.91 | SPHK1 (0.83) | SPHK1SPHK2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL12450365 | 0.88 | SPHK1 (0.79) | SPHK1SPHK2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL13499031 | 0.88 | SPHK1 (0.79) | SPHK1SPHK2 | |
| SCHEMBL20168989 | 0.87 | SPHK1 (0.77) | SPHK1SPHK2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL22861894 | 0.87 | SPHK1 (0.77) | SPHK1SPHK2CYP3A4CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 221 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4735431-A2 | MK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME | GILEAD SCIENCES, INC. (US) | 2026-05-06 | — | — | EP | claimed |
| EP-4674484-A2 | THIENOPYRROLE COMPOUNDS | Gilead Sciences, Inc. (US) | 2026-01-07 | — | — | EP | claimed |
| EP-4291562-B1 | THIENOPYRROLE COMPOUNDS | GILEAD SCIENCES INC (US) | 2025-09-10 | — | — | EP | claimed |
| US-20250051309-A1 | MK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME | GILEAD SCIENCES, INC. | 2025-02-13 | — | — | US | claimed |
| US-20250049780-A1 | THIENOPYRROLE COMPOUNDS | GILEAD SCIENCES, INC. | 2025-02-13 | — | — | US | claimed |
| EP-3810285-B1 | SPHINGOSINE PATHWAY MODULATING COMPOUNDS FOR THE TREATMENT OF CANCERS | ENZO BIOCHEM INC (US) | 2025-02-12 | — | — | EP | claimed |
| WO-2025006568-A2 | MK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME | GILEAD SCIENCES, INC. (US) | 2025-01-02 | — | — | WO | claimed |
| US-12070455-B2 | Thienopyrrole compounds | GILEAD SCIENCES, INC. (US) | 2024-08-27 | — | — | US | claimed |
| EP-4398989-A1 | THIENOPYRROLE COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2024-07-17 | — | — | EP | claimed |
| CN-117957234-A | Thienopyrrole compounds | 吉利德科学公司 | 2024-04-30 | — | — | CN | claimed |
| EP-4036583-A1 | TARGETING KINASES FOR THE TREATMENT OF CANCER METASTASIS | Board of Regents, The University of Texas System (US) | 2022-08-03 | — | — | EP | claimed |
| WO-2022140325-A1 | 6-SUBSTITUTED INDOLE COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2022-06-30 | — | — | WO | claimed |
| WO-2022140326-A1 | SUBSTITUTED INDOLE COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2022-06-30 | — | — | WO | claimed |
| WO-2022015348-A1 | SPHINGOID COMPOUNDS FOR USE IN PROPHYLAXIS AND/OR THERAPY OF CORONAVIRIDAE INFECTION | Harbins Ruhr Bioscience, Inc. (US) | 2022-01-20 | — | — | WO | claimed |
| EP-3863616-A2 | SPHINGOID COMPOUNDS FOR USE IN THE PROPHYLAXIS AND/OR THERAPY OF A VIRAL INFECTION | Harbins Ruhr Bioscience, Inc. (US) | 2021-08-18 | — | — | EP | claimed |
| US-20180110757-A1 | METHODS OF TREATING PRURITIS AND PAIN | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2018-04-26 | — | — | US | claimed |
| US-20170252311-A1 | SPHINGOSINE KINASE INHIBITORS AND CERAMIDE FOR MAINTENANCE THERAPY OF GLIOBLASTOMA | SIGNPATH PHARMA INC. | 2017-09-07 | — | — | US | claimed |
| US-20150126564-A1 | MODULATION OF SPHINGOSINE 1-PHOSPHATE METABOLIZING ENZYMES FOR THE TREATMENT OF NEGATIVE-STRAND RNA VIRUS INFECTIONS | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2015-05-07 | — | — | US | claimed |
| US-20140056917-A1 | FTY720 Increases CD74 Expression and Sensitizes Cancer Cells to Anti-CD74 Antibody-Mediated Cell Death | IMMUNOMEDICS, INC. (US) | 2014-02-27 | — | — | US | claimed |
| WO-2012166859-A2 | MODULATION OF SPHINGOSINE 1-PHOSPHATE METABOLIZING ENZYMES FOR THE TREATMENT OF NEGATIVE-STRAND RNA VIRUS INFECTIONS | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2012-12-06 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250049780-A1 | THIENOPYRROLE COMPOUNDS | SSB, TPMT, LCP2 | SPHK1 187/4885SPHK2 113/4885CYP3A4 2014/4885 |
| US-20250051309-A1 | MK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME | DUSP2, MKNK2, DUSP22 | SPHK1 857/4885SPHK2 159/4885CYP3A4 4634/4885 |
| US-12070455-B2 | Thienopyrrole compounds | SSB, TPMT, LCP2 | SPHK1 187/4885SPHK2 113/4885CYP3A4 2014/4885 |
| US-20180110757-A1 | METHODS OF TREATING PRURITIS AND PAIN | CYSLTR2, LTB4R2, CYSLTR1 | SPHK1 1041/4885SPHK2 903/4885CYP3A4 4131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.